List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #40,401 to #40,450.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. PRAISE-1 → Prospective Randomized Amlodipine Survival Evaluation-1
  2. PRAISE-2 → Prospective Randomized Amlodipine Survival Evaluation-2
  3. PREAMI → Perindopril Remodeling In Elderly With Acute Myocardial Infarction
  4. PRECISE → Double-Blind, Placebo-Controlled Study Of The Effects Of Carvedilol In Patients With Moderate To Severe Heart Failure
  5. PREDICT → Effect Of Pravastatin On Angiographic Restenosis After Coronary Balloon Angioplasty
  6. PREMIAR → Protection From Distal Embolization In High-Risk Patients With Acute St-Segment Elevation Myocardial Infarction
  7. PREMIER → Effects Of Pg-116800, A Matrix Metalloproteinase Inhibitor, To Prevent Left Ventricular Remodeling After Acute Myocardial Infarction
  8. PREPAIR → Clopidogrel 600-Mg Double Loading Dose Achieves Stronger Platelet Inhibition Than Conventional Regimens
  9. PREPARE — Presented at TCT 2008 → Proximal Embolic Protection In Acute Mi And Resolution Of St-Elevation
  10. PREPIC → A Clinical Trial Of Vena Caval Filters In The Prevention Of Pulmonary Embolism In Patients With Proximal Deep-Vein Thrombosis
  11. PRESENT → Preliminary Safety Evaluation Of Nanoporous Tacrolimus Eluting Stents
  12. PRESERVE → Prospective Randomized Trial Of Enalapril To Reverse Ventricular Enlargement
  13. PRESTO → Results Of Prevention Of Restenosis With Tranilast And Its Outcomes (Presto) Trial.
  14. PREVEND IT → Prevention Of Renal And Vascular End-Stage Disease Intervention Trial
  15. PREVENT(Radiation) → Proliferation Reduction With Vascular Energy Trial
  16. PREVENT (Dalteparin) → Prospective Evaluation Of Dalteparin Efficacy For Prevention Of Vte In Immobilized Patients Trial
  17. PREVENT (Warfarin) → Venous thromboembolism
  18. PREVENT II → The Program In Ex Vivo Vein Graft Engineering Via Transfection II Study: E2F Decoy In Cabg
  19. PREVENT IV → Project Of Ex-Vivo Vein Graft Engineering Via Transfection
  20. PRF1 → Perforin
  21. PRIDE → A Prospective, Randomized, Controlled Trial Of Distal Protection With The Kensey-Nash Triactiv System Compared To The Guardwire Or Filterwire
  22. PRIMA — Presented at ACC.09/i2 → Can Pro-Brain Natriuretic Peptide Guided Therapy Of Heart Failure Improve Heart Failure Morbidity And Mortality?
  23. PRIME-2 → Second Prospective Randomized Study Of Ibopamine On Mortality And Efficacy In Heart Failure
  24. PRIMI → Pro-Urokinase For Myocardial Infarction
  25. PRIMO-CABG → Pexelizumab For The Reduction Of Infarction And Mortality In Coronary Artery Bypass Graft Surgery Study
  26. PRIMO-CABG II → Pexelizumab For The Reduction Of Infarction And Mortality In Coronary Artery Bypass Graft II
  27. PRINCE → Effect Of Statin Therapy On C-Reactive Protein Levels: The Pravastatin Inflammation/Crp Evaluation (Prince): A Randomized Trial And Cohort Study
  28. PRINCESS → Prevention Of Ischaemic Events By Early Treatment Of Cerivastatin After Acute Myocardial Infarction
  29. PRINCIPLE-TIMI 44 → The Prasugrel In Comparison To Clopidogrel For Inhibition Of Platelet Activation And Aggregation–Thrombolysis In Myocardial Infarction 44 Trial
  30. PRISM → Platelet-Receptor Inhibition For Ischemic Syndrome Management
  31. PRISM-PLUS → Platelet-Receptor Inhibition For Ischemic Syndrome Management In Patients Limited By Unstable Signs And Symptoms
  32. PRISM-Troponin → Troponin Levels Identify Cad Patients Likely To Benefit From Tirofiban: Results From The Prism-Troponin Study, A Substudy Of The Platelet Receptor Inhibition In Ischemic Syndrome Management Study
  33. PRISON II → Prospective Randomized Trial Of Sirolimus-Eluting And Bare Metal Stents In Patients With Chronic Total Occlusions
  34. PRKACB gene → PRKACB
  35. PRKAR1A gene → PRKAR1A
  36. PRL cell adenoma → Prolactinoma
  37. PRL cell tumor → Prolactinoma
  38. PRL secreting adenoma → Prolactinoma
  39. PRL secreting pituitary adenoma → Prolactinoma
  40. PRL tumor → Prolactinoma
  41. PRNT → Plaque reduction neutralization test
  42. PROCAM → Simple Scoring Scheme For Calculating The Risk Of Acute Coronary Events Based On The 10-Year Follow-Up Of The Prospective Cardiovascular Münster (Procam) Study
  43. PRODH → Proline oxidase
  44. PROFILE → Prospective Randomized Flosequinan Longevity Evaluation
  45. PROGRESS → Perindopril Protection Against Recurrent Stroke Study
  46. PROGRESS-1 → Coronary Stenting With Absorbable Metal Stents
  47. PROLONG study → PROLONG Study
  48. PROM → Premature rupture of membranes
  49. PROMM → Myotonic dystrophy
  50. PROSPER → PROSPER Trial

View ( | ) (20 | 50 | 100 | 250 | 500)